RxDoctor Payments Data

Jennifer Romeyk, DPM

Podiatrist · Lindenhurst, NYNPI 1134287949

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $310, 2.6 times the $121 reported in 2023. That places this record below the midpoint for podiatrist clinicians in NY, where the typical reported total is $506.

$460in general payments, 2019–2025

Across 17 payments — averaging $27.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$94
  • Smith+Nephew$80
  • Organogenesis Inc.$52
  • Johnson & Johnson$42
  • Bone Support Inc.$32
  • Bioventus LLC$29
  • plus $131 from 6 others

What the payments were for

  • Food & beverage$460100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$460 in reported general payments places this provider in the 45th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York →

Medicare billing

Part B allowed, 2024
$115,249
Medicare patients
493
Services billed
1,982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other podiatrist in Lindenhurst

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →